![风湿免疫科专业英语_第1页](http://file1.renrendoc.com/fileroot_temp2/2020-12/5/184dcbfa-7ec6-4aba-aff4-ffd6655a16d3/184dcbfa-7ec6-4aba-aff4-ffd6655a16d31.gif)
![风湿免疫科专业英语_第2页](http://file1.renrendoc.com/fileroot_temp2/2020-12/5/184dcbfa-7ec6-4aba-aff4-ffd6655a16d3/184dcbfa-7ec6-4aba-aff4-ffd6655a16d32.gif)
![风湿免疫科专业英语_第3页](http://file1.renrendoc.com/fileroot_temp2/2020-12/5/184dcbfa-7ec6-4aba-aff4-ffd6655a16d3/184dcbfa-7ec6-4aba-aff4-ffd6655a16d33.gif)
下载本文档
版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领
文档简介
1、一、英译汉A 30-year-old woman presented to the office with a complaint of intermittent episodes of pain, stiffness, and swelling in both hands and wrists for approximately 1 year. The episodes lasted for several weeks and then resolved. More recently, she noticed similar symptoms in her knees and ankles.
2、 Joints pain and stiffness were making it harder for her to get out of bed in the morning and were interfering with her ability to perform her duties at work. The joint stiffness usually lasted for several hours before improving. She also reported malaise and easy fatigability for the past few month
3、s, but she denied having fever, chills, skin rashes, and weight loss. Physical examination revealed a well-developed woman, with blood pressure 120/70 mmHg, heart rate 82 bpm , and respiratory rate 14 breaths per minute. Her skin did not reveal any rashes. Her head, neck, cardiovascular, chest, and
4、abdominal examinations were negative. There was no hepatosplenomegaly. The joint examination revealed the presence of bilateral swelling, redness and tenderness of most proximal interphalangeal(PIP) joints, the wrists , and knees.二、汉译英你可能会出现下列症状和体征:1、关节肿胀、疼痛、局部发热;2、晨僵,常超过1个小时;3、手臂包块(类风湿结节);4、疲劳或体重减轻
5、。早期类风湿关节炎以影响手足的小关节常见,如掌指关节、近端指间关节。随病情发展,症状常蔓延至腕、肘、肩、膝和踝部。大多数情况下,类似的关节症状会在身体两侧出现,我们称之为“对称性”。类风湿关节炎的严重程度因患者不同有所差异,而同一患者的病情也常反复。最终可导致关节变形和功能受限。三、阅读写作Adult-onset Stills disease (AOSD) is an uncommon systemic inflammatory disease of unknown aetiology. Although its clinical picture tends to be very hetero
6、ge- neous, it typically presents with spiking fever, arthritis or arthralgia, an evanescent rash and leukocytosis. Up to 80% of AOSD cases can be controlled with corticosteroids ; however, reports on cases unresponsive to cortico- steroids, conventional disease modifying drugs and biolog- ical agent
7、s, including anti-IL1 inhibitors, are emerging. We present a case of AOSD with severe poylarthritis unrespon- sive to corticosteroids, methotrexate, anakinra and etaner- cept, but successfully stabilised with a humanized monoclonal anti-IL-6 receptor antibody, tocilizumab. A 35-year old man presente
8、d with a fever of up to 40C, severe arthralgia and myalgia, and a palpable hepatomeg- aly. Laboratory tests showed leukocytosis (up to 23 109/l; normal, 410 109/l; 16.5 109/l granulocytes), elevated liver enzymes (AST 3.40 kat/l; normal, 0.5 kat/l; ALT, 2.61 kat/l; normal, 0.42 kat/l; CRP 237 mg/l;
9、normal, 5 mg/l) and feritin (13,871 g/l; normal 20 300 g/l), while RF, ACPA, ANA, ENA, ANCA, anti- DNA and ACE were all negative. An abdominal ultrasound confirmed hepatosplenomegaly, and there were bilateral pleural effusion and enlarged mediastinal and hilar lymph nodes visible on the chest CT sca
10、n. All microbiologic tests including a Quantiferon-TB gold test were negative, while a mediastinal lymph node biopsy revealed reactive changes. He was diagnosed with AOSD by fulfilling three major and three minor criteria described by Yamaguchi et al. while other inflammatory, infective or neoplasti
11、c causes were excluded. Initial parenteral methylprednisolone (80 mg daily) had failed to produce a significant clinical response. Six weeks later, anakinra (100 mg daily subcu- taneously) was introduced. An excellent clinical and laboratory improvement followed; however, 2 months later the disease
12、flared-up again with a fever of up to 38C, elevated CRP (98 mg/l) and for the first time polyarthritis. Methotrexate (25 mg weekly) was added to the anakinra (100 mg subcutaneously daily), and methylprednisolone (8 mg daily) without success. Thereafter, we discontinued anakinra and introduced an ant
13、i TNF-alpha agent (etaner- cept, 50 mg subcutaneously weekly). The administration of methotrexate (25 mg weekly) and methylprednisolone (8 mg daily) was continued. After 3 months of treatment, the polyarthritis affecting small joints, wrists and left knee and tenosynovitis of the extensor carpi radi
14、alis muscles persisted. Laboratory tests showed an increased sedimentation rate (SR, 67 mm/h; normal 15 mm/h), elevated CRP (100 mg/l), leukocytosis (12.3109/l, 10.1 109/l granulocytes) and elevated IL-6 (33 pg/ml, normal 8 pg/ml). We discontinued etanercept and after obtaining a written patient inf
15、ormed consent, we started to administer tocilizumab 8 mg/kg intravenously every 4 weeks, with methotrexate (15 mg weekly) and methyl- prednisolone (8 mg daily) as concomitant therapy. The clinical status improved remarkably within days and his laboratory tests normalised completely by the fifth toci
16、lizumab administration. After 7 months of tocilizumab treatment, he is doing well, currently maintained on tocilizumab 8 mg/kg every 4 weeks, methotrexate 7.5 mg weekly and methylprednisolone 3 mg daily. Discussion Various cytokines, IL-1b and IL-6 among them, are believed to play a major role in AO
17、SD 1. Although corticosteroids currently remain the first line therapy for AOSD patients, followed by traditional DMARDs, refractory cases present an incentive for developing new effective therapeutic options. Four cases of successful tocilizumab treatment in refractive AOSD patients have been descr
18、ibed up to now (Table 1). In one of them, other biological agents, including anakinra as in our patient, were tried before tocilizumab. The initial tocilizumab dosing ranged from 4 mg/kg weekly to 8 mg/kg fortnightly, and we expanded this interval to 8 mg/kg monthly, which is the approved tocilizuma
19、b dosing in RA patients. As far as we know, this is the first reported case of a refractive AOSD patient, who responded well to tocilizumab treatment administered once monthly from the very beginning. We observed a rapid and stable clinical and laboratory improve- ment. Our patient received tocilizumab primarily for refractive poly
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 业务部股权激励协议
- 招标投标与合同管理教材
- 2020年清单计价规范epc项目总价合同
- 2023年日照市城乡小学教师选调考试真题及答案
- 晋中太谷事业单位笔试真题及答案2024
- 承德双桥事业单位笔试真题及答案2024
- (高清版)GB∕T 37666-2019 古陶瓷中子活化分析技术规范
- (高清版)GB∕T 37506-2019 烟蚜茧蜂防治烟蚜技术规程
- 广州市萝岗区乐安居房地产服务中心员工招聘问题及对策研究
- 物理:沪粤版八年级 探究杠杆的平衡条件(教案)2
- 新高速公路护坡劳务合同2024年
- 藤编工艺在非物质文化遗产保护考核试卷
- 2024年北京市中考物理试题(含答案及解析)
- NB-T+31010-2019陆上风电场工程概算定额
- 借款合同的会议记录
- JT-T-617.7-2018危险货物道路运输规则第7部分:运输条件及作业要求
- 2024年动物屠宰检疫及疫病检验员等技能及相关规定知识试题库(附含答案)
- 2024年高考英语新课标II卷及答案
- 土力学与地基基础(课件)
- 上海市小学三年级数学下学期期末考试试题 含答案
- 三才配置一览表
评论
0/150
提交评论